COPD Flashcards
COPD management is based on
symptom burden and risk for exacerbation. airflow limitation by FEV1 is considered but plays a smaller role since it provides a poorer correlation w/ symptoms and quality of life.
Groups B-D COPD should get
pulmonary rehab and this is based on their risk for having exacerbation >2 per year.
why is pulmonary rehab so good for COPD?
COPD pts often limit physical activity as this exercise worsens their dyspnea and leads to deconditioning and creates a physical vicious cycle of having dyspnea happening at lower levels of activity. Rehab breaks the cycle
what happens a pulmonary rehab?
consists of conditioning, breathing training, psychological support and dx education and helps to break the cycle and improve symptoms, increases exercise capacity and quality of life.
lung volume reduction surgery helps with COPD pts who have
upper lobe emphysema and low exercise capacity. meant for select pts with severe COPD who fail maximal therapy.
When do we use theophylline?
given to pts who have refractory disease on triple inhaler therapy (beat agonists, antimuscarinics and corticosteroids) helps with modest bronchodilation and requires close monitoring to prevent toxicity
when do we offer oxygen therapy for COPD pts?
improves survival and quality of life with chronic hypoxia when
resting PaO2< 55 mmHg or SpO2<88.
resting PaO2<59 or SaO2 <89 + have cor pulmonale (right sided heart failure) or erythrocytosis (hematocrit>55%)
Oxygen should be titrate to maintain SaO2 of 90-92% and should be used for 15 hrs per day or more.
PaO2 <55mg or SaO2<88 during exercise or sleep many benefit from supplemental oxygen therapy during those times too.
GOLD grade 1 COPD
mild FEV1>80% of predicted
GOLD grade 2 COPD
moderate FEV1 is between 50-80% of predicted
GOLD grade 3 COPD
severe FEV1 is between 30-50% predicted
GOLD grade 4 COPD
very severe FEV1<30% predicted
palliative care in COPD principles
treat underlying dx supplemental oxygen pulmonary rehab
If this fails due to worsening dyspnea, consider opioids (long and short acting), facial cooling, consider anxiolytics or consider theophylline
If dyspnea worsens consider end of life care with palliative sedation and non invasive positive pressure ventilation
pts with advanced COPD should be on
triple inhaler therapy (long acting beta agonist, long acting anticholinergic, and glucosteroid)
what can help relieve dyspena or sense of breathlessness in pts with end stage lung disease
opioids - underused by clinicians for fear or respiratory depression, addiction and dependence. societal and patient factors also limit their use.
roflumilast therapy provides what benefit for COPD pts?
decreases risk for COPD exacerbation in pts with frequent exacerbations.